Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

In a series of articles to promote INVEST 2025 in Chicago April 29-30, we are highlighting investment insights and perspectives in the runup to the boutique event for traditional and strategic ...

The modern concept of “triage” dates to the Napoleonic Wars, when French battlefield surgeons developed a system for assessing the wounded and determining treatment priority to govern ...

Before the onset of the coronavirus pandemic in February 2020, there were 71 million people enrolled in Medicaid and Children’s Health Insurance Program (CHIP). Now, with the expiration of the ...

Pfizer’s research partnership with Sangamo Therapeutics produced a hemophilia A gene therapy that reached FDA discussions about a regulatory submission. That’s as far as the alliance will go.

The Uno Savings Guide is a free resource that helps people check their eligibility for financial benefit programs, like Medicaid, Medicare Savings Programs and SNAP.

Trinity Health Mid-Atlantic partnered with mental health software provider Neuroflow last August to mitigate healthcare's burnout crisis by providing its nurses with the Philadelphia-based startup ...

As Blue Shield Vice President, Pharmacy Services, Alison Lum leads the team that is transforming the Blue Shield pharmacy benefit into one that is worthy of our family and friends and sustainably ...

Agitation caused by Alzheimer’s disease currently has one FDA-approved therapy, but that drug brings serious safety risks. An Axsome Therapeutics drug has mixed results from its latest slate of ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment ...

Each year, billions of dollars in benefits are unused. Uno Health hopes to change this with its recent launch of the Uno Savings Guide, a resource that helps people determine their eligibility for ...

Bristol Myers Squibb has won FDA approval for an injectable version of its blockbuster cancer immunotherapy Opdivo, a regulatory decision that gives patients a more convenient dosing option and ...